Telaprevir Experience From Turkey

Telaprevir Experience From Turkey

BACKGROUND In patients with chronic hepatitis C, triple drug regimens containing a protease inhibitor, peginterferon and ribavirin were found to significantly increase sustained virologic response rates compared to dual drug regimen containing pegylated interferon and ribavirin, especially in genotype 1. OBJECTIVES In Turkey, telaprevir has been used since March 2013. We aimed to evaluate res...

telaprevir experience from turkey

background in patients with chronic hepatitis c, triple drug regimens containing a protease inhibitor, peginterferon and ribavirin were found to significantly increase sustained virologic response rates compared to dual drug regimen containing pegylated interferon and ribavirin, especially in genotype 1. objectives in turkey, telaprevir has been used since march 2013. we aimed to evaluate resul...

Comment to “Telaprevir Experience From Turkey”

We have read with great interest the article entitled " Telaprevir experience from Turkey " by Komur et al. recently (1). First of all, we have applauded the efforts of the authors and the editors of journal for putting forward this controversial and wondered topic for us. Currently, the hepatitis C treatment is in a very dynamic situation, due to newly introduced potent drugs. Therefore, the m...

comment to “telaprevir experience from turkey”

Tuberculosis verrucosa cutis. Experience from eastern Turkey.

T verrucosa cutis (TBVC) is a paucibacillary form of cutaneous tuberculosis caused by exogenous reinfection in previously sensitized individuals. Inoculation occurs at sites of minor wounds or abrasions, and rarely from the patient’s own sputum. The TBVC usually occurs on the hands in adults, and on the lower extremities in children. In western countries, TBVC is a rare form of cutaneous tuberc...